258 Anticancer activity of a novel kaempferol glucoside, Tac, is mediated by a mechanism involving RSK inhibition (original) (raw)
Related papers
A novel anti-melanoma SRC-family kinase inhibitor
Oncotarget, 2019
Applied sciences, 2022
Kinase Inhibitors from Marine Sponges
Marine Drugs, 2011
Anticancer alkaloid lamellarins inhibit protein kinases
Marine drugs, 2008
Mechanism-based isolation and structures of some anticancer active natural products
Pure and Applied Chemistry, 1994
T-kininogen, a cystatin-like molecule, inhibits ERK-dependent lymphocyte proliferation
Mechanisms of Ageing and Development, 2005
Anti-Cancer Drugs: Molecular Mechanisms of Action
Mini-Reviews in Medicinal Chemistry, 2005
Plant-derived anticancer agents: A green anticancer approach
Asian Pacific Journal of Tropical Biomedicine, 2017
Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters, 2013
Understanding how kinase-targeted therapies work
Cell Cycle, 2008
Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft
British Journal of Cancer, 2000
Specific delivery of kinase inhibitors in nonmalignant and malignant diseases
Expert Opinion on Drug Delivery, 2011
Inhibition of Protein Kinase c-Src as a Therapeutic Approach for Cancer and Bone Metastases
Anti-Cancer Agents in Medicinal Chemistry, 2008
Redesigning Kinase Inhibitors to Enhance Specificity
Journal of Medicinal Chemistry, 2008
Inhibition of the Canonical IKK/NFκB Pathway Sensitizes Human Cancer Cells to Doxorubicin
Cell Cycle, 2007
Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway
Current Pharmaceutical Design, 2012
Developmental & Comparative Immunology, 2010
RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer
Expert Opinion on Therapeutic Targets, 2019
Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer
Cancer prevention research (Philadelphia, Pa.), 2014
Inhibitors that target protein kinases for the treatment of ovarian carcinoma
American Journal of Obstetrics and Gynecology, 2003
2023
Bioassays for Anticancer Activities
Methods in Molecular Biology, 2013
Phase II study of a new vinca alkaloid derivative, S12363, in advanced breast cancer
Cancer Chemotherapy and Pharmacology, 1995
Anticancer Agents from Unique Natural Products Sources
Pharmaceutical Biology, 2003
ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases
Bioorganic & Medicinal Chemistry, 2004
Recent progress in cancer therapeutics
Translational oncology, 2009
Resveratrol and N-acetylcysteine block the cancer-initiating step in MCF-10F cells
Free Radical Biology and Medicine, 2011
Current Signal Transduction Therapy, 2013
Kaempferol: A Key Emphasis to Its Anticancer Potential
Molecules
Jakinibs: a new class of kinase inhibitors in cancer and autoimmune disease
Current Opinion in Pharmacology, 2012
Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms
Molecules, 2017
Development of Selective Alkaloid as an Anticancer Medicine from Natural Sources
2020
Improved Antiulcer and Anticancer Properties of a trans-Resveratrol Analog in Mice
Journal of Pharmacology and Experimental Therapeutics, 2009
Nature Structural & Molecular Biology, 2004